News Coverage 10.17.19 By: Mark Terry Share on Twitter Share on Facebook Share on LinkedIn ArsenalBio Launches with $28 Million Series A to Develop Next-Generation Immunotherapies Related Announcement, Our Impact, Press Release PICI at ASCO: New Data. Big Impact. Top Honors. Announcement, Partner Highlight, Press Release New PICI Collaboration Bolsters Science-to-Market Edge Announcement, Partner Highlight, Press Release PICI, Immunai to Build Landmark Cancer Dataset
Announcement, Partner Highlight, Press Release New PICI Collaboration Bolsters Science-to-Market Edge